Lauren DAngelo
Chief Operating Officer at ALPHA COGNITION INC.
Lauren DAngelo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALPHA COGNITION INC. | Chief Operating Officer | 01/01/2023 | - |
| Corporate Officer/Principal | 04/05/2021 | - |
Career history of Lauren DAngelo
Former positions of Lauren DAngelo
| Companies | Position | Start | End |
|---|---|---|---|
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Sales & Marketing | - | - |
Training of Lauren DAngelo
| Florida State University | Undergraduate Degree |
| University of Florida | Masters Business Admin |
Statistics
International
| United States | 4 |
| Canada | 2 |
Operational
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Private companies | 1 |
|---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
- Stock Market
- Insiders
- Lauren DAngelo
- Experience